Bio Rad Laboratories Inc/ US0905722072 /
17/07/2024 22:10:00 | Chg. +4.12 | Volume | Bid02:00:00 | Ask02:00:00 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
318.64USD | +1.31% | 217,667 Turnover: 31.2 mill. |
310.70Bid Size: 100 | 372.51Ask Size: 100 | 7.47 bill.USD | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -21.82 USD | -82.08% |
EPS Diluted: | -21.82 USD | -82.08% |
Revenues per Share: | 114.05 USD | -0.20% |
Book Value per Share: | 373.19 USD | -4.83% |
Cash Flow per Share: | 16.01 USD | 101.90% |
Dividend per Share: | - USD | - |
Total | in mill. | |
Revenues: | 2,671.26 USD | -4.67% |
Net Income: | -637.30 USD | -82.43% |
Operating Cash Flow: | 374.90 USD | - |
Cash and Cash Equivalents: | 403.82 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 2.79 | 2.83 |
P/BV ratio: | 0.85 | 0.87 |
P/CF Ratio: | 19.91 | 20.17 |
PEG: | 0.18 | - |
Earnings Yield: | -6.85% | -6.76% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 7.47 bill. USD | 7.56 bill. USD |
Free Float Market Cap.: | - USD | - USD |
Market Cap. / Employee: | - USD | - USD |
Shares Outstanding: | 23.45 mill. |
Profitability
Gross Profit Margin: | 53.42% |
EBIT Margin: | 12.65% |
Net Profit Margin: | -23.86% |
Return on Equity: | -7.29% |
Return on Assets: | -5.18% |
Financial Strength
Liquidity I / Cash Ratio: | 77.24% |
Liquidity II / Quick Ratio: | 170.78% |
Liquidity III / Current Ratio: | 583.08% |
Debt / Equity Ratio: | 40.70% |
Dynam. Debt / Equity Ratio: | 949.04% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | - USD |
Net Income / Employee: | - USD |
Total Assets / Employee: | - USD |
* Fiscal Year End: | 31/12/2023 |
Accounting Standard: | US GAAP |
Currency: | USD |